Ranbaxy wins patent case
A UK court has allowed Ranbaxy Laboratories to sell specified immediate release formulations of macrolide antibiotic Clarithromycin in the UK market. It ruled multinational drug major Abbott's patent
A UK court has allowed Ranbaxy Laboratories to sell specified immediate release formulations of macrolide antibiotic Clarithromycin in the UK market. It ruled multinational drug major Abbott's patent